Journal Information
Most often read
764
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative ColitisFrancisco Rodríguez-Moranta, Federico Argüelles-Arias, Joaquín Hinojosa del Val, Marisa Iborra Colomino, M. Dolores Martín-Arranz, Luis Menchén Viso, Fernando Muñoz Núñez, Elena Ricart Gómez, ... Ana Gutiérrez Casbas
Gastroenterol Hepatol. 2024;47:522-52
764
Full text access
Open Article
284
Asociación Española de Neurogastroenterología y Motilidad (ASENEM) updated review on the management of functional abdominal painJordi Serra, Ariadna Aguilar, Elizabeth Barba, Constanza Ciriza de los Ríos, Laura Garcia Pravia, Vicente Martínez, Blanca Serrano Falcón
Gastroenterol Hepatol. 2024;47:888-900
284
Full text access
Open Article
268
Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on sexuality and inflammatory bowel diseaseMarta Calvo Moya, Francisco Mesonero Gismero, Cristina Suarez Ferrer, Alejandro Hernández-Camba, Danízar Vásquez Carlón, Fátima García Benasach, Mariam Aguas Peris, Francisco José Delgado Oliva, ... on behalf of GETECCU
Gastroenterol Hepatol. 2024;47:774-92
268
Full text access
Open Article
254
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCUMar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, ... María-Carlota Londoño
Gastroenterol Hepatol. 2024;47:401-32
254
Full text access
Open Article
242
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: Results of a Delphi studyRocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes, Omar J. Benmarzouk-Hidalgo, Rafael Subirán, Alicia Gil
Gastroenterol Hepatol. 2024;47:337-46
242
Full text access
Open Article
222
Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processingJose Luis Calleja-Panero, Rafael Esteban Mur, Isidro Jarque, Manuel Romero-Gómez, Savana Research Group, Lucia García Labrador, Jose González Calvo
Gastroenterol Hepatol. 2024;47:236-45
222
Full text access
Open Article
212
Recommendations and quality criteria to improve the early diagnosis of primary biliary cholangitisÁlvaro Díaz-González, Noelia Fontanillas, Eva Gil-Hernández, Mercedes Guilabert, Maria-Carlota Londoño, Mar Noguerol, Fernando Pérez Escanilla, José J. Mira, Manuel Santiñá
Gastroenterol Hepatol. 2024;47:834-44
212
Full text access
Open Article
211
Prognostic value of abnormal liver function test for hospitalized patients with COVID-19Carlos Alventosa Mateu, Salvador Benlloch, Moisés Diago
Gastroenterol Hepatol. 2024;47:192-3
211
197
Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM studyDomingo Balderramo, Jesús Yamamoto-Furusho, Enrique Ponce de León, Julio de María, Ignacio Zubiaurre, Silvia Pedreira, Camilo Lis, Laura Brion, Juan A. de Paula
Gastroenterol Hepatol. 2024;47:51-62
197
Full text access
Open Article
188
Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn’s Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED)Eugeni Domènech, Andreea Ciudin, José María Balibrea, Eduard Espinet-Coll, Fiorella Cañete, Lilliam Flores, Manuel Ferrer-Márquez, Román Turró, ... on behalf of the GETECCU-SEEDO-AEC-SEED Consensus Group
Gastroenterol Hepatol. 2024;47:906-23
188
Full text access
Open Article
179
Enteric duplication cyst as a rare presentation of adult acute abdomenGerard Rafart, Clara Bassaganyas, Xavier Morales, Míriam Cuatrecasas, Jordi Rimola
Gastroenterol Hepatol. 2024;47:389-90
179
Full text access
Open Article
168
An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresisIago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada
Gastroenterol Hepatol. 2024;47:347-51
168
Full text access
Open Article
144
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN studyAnum Shaikh, Gabriel Pedra, Leonardo Ruiz-Casas, Bethany Franks, Harpal Dhillon, João Diogo da Rocha Fernandes, Kamal Kant Mangla, Margarida Augusto, ... Jörn M. Schattenberg
Gastroenterol Hepatol. 2024;47:463-72
144
Full text access
Open Article
123
Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathwayYanghui Bi, Liping Zhang, Yan Song, Lijun Sun, Michael W. Mulholland, Yue Yin, Weizhen Zhang
Gastroenterol Hepatol. 2024;47:352-65
123
Full text access
Open Article
121
Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in ArgentinaLisandro Pereyra, Leandro Steinberg, Juan Lasa, Agustina Marconi, Audrey H. Calderwood, María Pellisé
Gastroenterol Hepatol. 2024;47:140-8
121
112
Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease—EXVEDOCOLViviana Parra, Sandra Cifuentes, Sandra Avendaño, Enrique Ponce de León, Cristian Florez, Gustavo Reyes, Fabian Puentes, Manuel Ballesteros, ... Juan Ricardo Márquez
Gastroenterol Hepatol. 2024;47:858-66
112
Full text access
Open Article
109
Black esophagus: Massive bleeding in cirrhosis does not always mean variceal ruptureVítor Macedo Silva, Ana Isabel Ferreira, Pedro Boal Carvalho, Joana Magalhães, José Cotter
Gastroenterol Hepatol. 2024;47:504-5
109
Full text access
Open Article
104
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study)Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, Belén Beltrán, Eugeni Domènech, Ana Gutiérrez Casbas, Miriam Mañosa, Yamile Zabana, ... Santiago García-López
Gastroenterol Hepatol. 2024;47:750-8
104
97
Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospitalCristina Suárez Ferrer, Eduardo Martin-Arranz, María Dolores Martín-Arranz
Gastroenterol Hepatol. 2024;47:721-6
97
Full text access
Open Article
85
Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective studyIago Rodríguez-Lago, Fiorella Cañete, Elena Guerra-del-Río, Claudia Herrera-deGuise, Eva Iglesias, Eduardo Leo, Yamile Zabana, Manuel Barreiro-de Acosta, ... José Luis Cabriada
Gastroenterol Hepatol. 2024;47:727-33
85
Full text access
Open Article